Vaishali Pharma Ltd.

6.95

0 (0.4%)growUp

As on May 14, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap75 Cr
P/E Ratio110.85
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open6.92
High7.19
NSE SymbolVAISHALI
Close6.95
Low6.75
BSE Symbol
Previous Years High/Low
1 Year High13.59
3 Year High24.91
5 Year High24.91
1 Year Low4.75
3 Year Low4.75
5 Year Low2.89

Technicals


IndicatorsValueSignal
5-DMA7.19Bearish
10-DMA7.37Bearish
20-DMA7.7Bearish
50-DMA6.8Bullish
100-DMA7.59Bearish
200-DMA9.26Bearish

Historical Performance


1 Year
-43.3%
3 Years
-50.9%
5 Years
72%
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:11.5
3 Years:-20.3
TTM:-43.4
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 110.85, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -20.4%, indicating poor shareholder returns.
  • The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹38 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹990 million, indicating a relatively small business scale.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 566422.2
No. of Shares: 81500 (Approx)
Performance:-43.4%
P/L: ₹-433577.8
NIFTY Performance: -5.5%
1 day Top Gainers
SymbolChange%
SAREGAMA384.55(15%)
NLCINDIA370.9(14%)
CAPLIPOINT2023.8(10%)
ADANIENT2712.9(9%)
CIPLA1436.7(8%)
1 Day Top Losers
SymbolChange%
KAYNES3336.5(-20%)
GRSE2705.4(-5%)
POLYMED1521(-5%)
DCMSHRIRAM1127.6(-5%)
TIINDIA2800.8(-5%)
PERSISTENT4628.8(-5%)
DATAPATTNS4010.5(-4%)
LICHSGFIN560.4(-4%)

Top Performing Stocks from the same sector


Zim Laboratories Ltd.

37.5%

100.01

1 Month Performance

Valiant Laboratories Ltd.

36%

79.39

1 Month Performance

Gujarat Themis Biosyn Ltd.

31.8%

373

1 Month Performance

Orchid Pharma Ltd.

31.6%

719.25

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

30.6%

109.35

1 Month Performance

Aarey Drugs & Pharmaceuticals Ltd.

27.8%

91.3

1 Month Performance

Haleos Labs Ltd.

26%

1611

1 Month Performance

Innova Captab Ltd.

25.6%

871.9

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month